Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 3.929E-09 | 8.556E-06 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 2.332E-07 | 2.207E-04 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 4.780E-07 | 3.589E-04 | FABP3, FFAR1, PPARG, TLR2 |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 2.053E-06 | 1.208E-03 | FFAR4, PPARA, PPARD, PPARG |
BP | GO:0008283; cell proliferation | GO:0048660; regulation of smooth muscle cell proliferation | 3.148E-06 | 1.672E-03 | HPGD, PPARD, PPARG, TERT |
BP | GO:0050896; response to stimulus | GO:0032868; response to insulin | 4.370E-06 | 2.213E-03 | FABP3, PPARA, PPARG, TLR2 |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 6.423E-06 | 3.108E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 9.631E-06 | 3.813E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 9.631E-06 | 3.813E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 9.631E-06 | 3.813E-03 | ALOX15, HPGD |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa03320 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.747E-14 | 2.279E-12 | FABP2; FABP3; FABP4; FABP5; PPARG; PPARA; PPARD |
hsa04923 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 9.011E-04 | 2.163E-02 | FABP4; TSHR |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Melanoma | C43 | TERT; TLR2 |
C00-D49: Neoplasms | Cancer | C00-C96 | TLR2 |
C00-D49: Neoplasms | Prostate cancer | C61 | TERT; TLR2 |
C00-D49: Neoplasms | Brain cancer | C71, D33 | TERT |
C00-D49: Neoplasms | Breast cancer | C50 | TERT |
C00-D49: Neoplasms | Tumors | C00-D48 | TERT |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TLR2 |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | FAAH |
C00-D49: Neoplasms | Myelodysplastic syndrome | D46 | TLR2 |